Beone Medicines Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Beone Medicines Ltd 's inventory turnover ratio sequentially decreased to 1.15 in the first quarter 2026, unsurprisingly, as the Beone Medicines Ltd markets continue to deteriorate, and ONC's faces growing challenges to bring down its inventories. Beone Medicines Ltd 's average inventory processing period in the Mar 31 2026 quarter, has increased to 317 days, from 292 days, in the Dec 31 2025 quarter.

Within Healthcare sector 295 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1212 in the fourth quarter 2025, to 1510.

ONC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Beone Medicines Ltd Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ONC Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	37.79 %	22.88 %	23.17 %	13.45 %	10.58 %
Y / Y Cost of Sales Growth	1.21 %	-	15.29 %	18.84 %	33.06 %
Inventory Turnover Ratio (TTM)	1.15	1.25	1.04	1.04	1.01
ONC's Total Ranking	# 1510	# 1212	# 1693	# 1694	# 813
Average inventory processing period	317	292	352	352	360
Seq. Inventory Growth	12.06 %	14.4 %	5.73 %	1.66 %	-0.07 %
Seq. Cost of Sales Growth	16.78 %	-27.04 %	19.51 %	-0.61 %	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 83
Healthcare Sector	# 296
Overall Market	# 1510

Inventory Turnover Ratio Statistics
High	Average	Low
2.85	1.48	0.95
(Mar 31 2019)		(Dec 31 2024)

ONC Company Profile >> Back to ONC Efficiency Comparisons >> Compare ONC Inventory Turnover Ratio to its Competitors

Financial Statements
Beone Medicines Ltd 's Inventories	$ 682 Millions	Visit ONC's Balance sheet
Beone Medicines Ltd 's Cost of Revenues TTM	$ 670 Millions	Visit ONC's Income Statement
What are ONC's Sales?		Visit ONC's Sales by Segment

Other Inventory Turnover Ratios
Beone Medicines Ltd 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ONC's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ONC's Competitors
Inventory Turnover Ratio for ONC's Suppliers
Inventory Turnover Ratio for ONC's Customers

You may also want to know
ONC's Sales Growth Rates	ONC's Pe Price to earnings ratio	ONC's Receivables Turnover Ratio	ONC's Stock Quote
ONC's Net Income Growth Rates	ONC's Ps Price to Sales ratio	ONC's Sales per Employee	ONC's Asset Turnover Ratio
ONC's Net Margin	ONC's Pb Price to Book ratio	ONC's Financial Strength Ratios	ONC's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Neogen Corporation	2.70	$ 478.000 Millions	$ 177 Millions
Merck and Co Inc	2.62	$ 17,158.000 Millions	$ 6,546 Millions
Ligand Pharmaceuticals Incorporated	2.62	$ 32.548 Millions	$ 12 Millions
Electrocore Inc	2.57	$ 4.012 Millions	$ 2 Millions
Anika Therapeutics Inc	2.57	$ 48.000 Millions	$ 19 Millions
Illumina Inc	2.54	$ 1,485.000 Millions	$ 585 Millions
Ani Pharmaceuticals Inc	2.53	$ 361.855 Millions	$ 143 Millions
Urogen Pharma Ltd	2.50	$ 14.967 Millions	$ 6 Millions
International Stem Cell Corporation	2.49	$ 3.995 Millions	$ 2 Millions
Quidelortho Corp	2.46	$ 1,462.500 Millions	$ 595 Millions
Pro dex Inc	2.45	$ 53.903 Millions	$ 22 Millions
Avanos Medical Inc	2.44	$ 355.900 Millions	$ 146 Millions
Aquestive Therapeutics Inc	2.43	$ 18.372 Millions	$ 8 Millions
United Therapeutics Corporation	2.41	$ 425.300 Millions	$ 177 Millions
Merit Medical Systems Inc	2.37	$ 791.837 Millions	$ 334 Millions
Viatris Inc	2.34	$ 9,553.100 Millions	$ 4,075 Millions
Perrigo Company Plc	2.34	$ 2,760.400 Millions	$ 1,178 Millions
Caredx Inc	2.34	$ 64.029 Millions	$ 27 Millions
Amgen Inc	2.33	$ 14,781.000 Millions	$ 6,335 Millions
Angiodynamics Inc	2.32	$ 142.000 Millions	$ 61 Millions
Neuroone Medical Technologies Corp	2.31	$ 4.423 Millions	$ 2 Millions
China Pharma Holdings Inc	2.29	$ 3.698 Millions	$ 2 Millions
Cytosorbents Corporation	2.29	$ 10.000 Millions	$ 4 Millions
Teleflex Incorporated	2.28	$ 1,300.454 Millions	$ 570 Millions
Vivos Inc	2.27	$ 0.136 Millions	$ 0 Millions
Beta Bionics Inc	2.26	$ 47.000 Millions	$ 21 Millions
Resmed Inc	2.26	$ 2,094.000 Millions	$ 927 Millions
Apyx Medical Corp	2.26	$ 20.000 Millions	$ 9 Millions
Tela Bio Inc	2.25	$ 26.000 Millions	$ 12 Millions
Eton Pharmaceuticals Inc	2.21	$ 39.000 Millions	$ 18 Millions

Date modified: 2026-08-29T17:37:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.